TG Therapeutics Inc (NAS:TGTX)
$ 16.48 -0.94 (-5.4%) Market Cap: 2.55 Bil Enterprise Value: 2.45 Bil PE Ratio: 74.91 PB Ratio: 15.91 GF Score: 75/100

TG Therapeutics Inc Update Call Transcript

Apr 18, 2022 / 12:30PM GMT
Release Date Price: $6.92 (-21.81%)
Operator

Greetings. Welcome to the TG Therapeutics Update Call. (Operator Instructions) Please note that this conference is being recorded. At this time, I'll now hand the call over to Jenna Bosco, Senior Vice President, Corporate Communications. Ms. Bosco, you may now begin.

Jenna Bosco
TG Therapeutics, Inc. - SVP of Corporate Communications

Thank you, and thanks, everyone, for joining us this morning. I'm Jenna Bosco, and with me today to discuss the recent regulatory updates for our oncology program as well as provide an overview of our commercialization efforts and financial position are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer.

Before we begin, I'd like to remind everyone that various remarks that we make about our future expectations, plans and prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. TG cautions that these forward-looking statements are subject to risks that may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot